Postmenopausal osteoporosis Trials in Łódź, Poland
Conditions / Postmenopausal osteoporosis / Łódź, Poland
Clinical trials for Postmenopausal osteoporosis investigate a range of treatment strategies and patient populations.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01343004 | Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women | COMPLETED | PHASE3 |
| NCT06577935 | A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01657162 | Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis | COMPLETED | PHASE3 |
| NCT02157948 | A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT00545363 | A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) | COMPLETED | PHASE4 |
| NCT05405725 | A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® | COMPLETED | PHASE3 |
| NCT01575834 | Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT04064411 | Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT04664959 | A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |
| NCT04934072 | A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis | COMPLETED | PHASE3 |